Cargando…

Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson’s Disease: A Nationwide Cohort Study

Background: Renin-angiotensin system (RAS) inhibitors have been suggested as protective agents in Parkinson’s disease (PD). However, epidemiological evidence on the association between RAS inhibitors and the development of PD is inconsistent. Objectives: To investigate the effect of RAS inhibitors o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Youngkwon, Kim, Seungyeon, Ye, Byoung Seok, Lee, Euni, Yu, Yun Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927987/ https://www.ncbi.nlm.nih.gov/pubmed/35308220 http://dx.doi.org/10.3389/fphar.2022.837890

Ejemplares similares

Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer’s disease: A nationwide population-based cohort study
por: Lee, Hyun Woo, et al.
Publicado: (2023)

Trimetazidine Use and the Risk of Parkinsonism: A Nationwide Population-Based Study
por: Kim, Seungyeon, et al.
Publicado: (2020)

Targeting Renin–Angiotensin System Against Alzheimer’s Disease
por: Gebre, Abadi Kahsu, et al.
Publicado: (2018)

Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
por: Szczepanska-Sadowska, Ewa, et al.
Publicado: (2021)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments
por: Atkinson, Jeffrey
Publicado: (2011)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
por: Mascolo, Annamaria, et al.
Publicado: (2021)

Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis
por: Xu, Ying, et al.
Publicado: (2021)

Evaluation of Prescription Medication Sharing Among Adults in South Korea: A Cross-Sectional Survey
por: Song, Seulki, et al.
Publicado: (2022)

Effects of the Local Bone Renin-Angiotensin System on Titanium-Particle-Induced Periprosthetic Osteolysis
por: Zhao, Zhiping, et al.
Publicado: (2021)

Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals
por: Egan, Brian M., et al.
Publicado: (2022)

G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?
por: Rodrigues-Ferreira, Sylvie, et al.
Publicado: (2015)

The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling
por: Gong, Xiaoxue, et al.
Publicado: (2019)

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
por: Ekholm, M., et al.
Publicado: (2021)

Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
por: Yang, Mengying, et al.
Publicado: (2020)

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review
por: Alshahrani, Saeed
Publicado: (2023)

Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin–Angiotensin System Inhibitors: The Detection of Signals of Drug–Drug Interactions
por: Inaba, Ichiro, et al.
Publicado: (2019)

Potassium Intake Prevents the Induction of the Renin-Angiotensin System and Increases Medullary ACE2 and COX-2 in the Kidneys of Angiotensin II-Dependent Hypertensive Rats
por: Gonzalez, Alexis A., et al.
Publicado: (2019)

Could Renin-Angiotensin System Inhibitors Be Protective From Severe COVID-19?
por: Carey, Robert M.
Publicado: (2021)

Therapeutic potential of Ganoderma lucidum polysaccharide peptide in Doxorubicin-induced nephropathy: modulation of renin-angiotensin system and proteinuria
por: Fang, Hui, et al.
Publicado: (2023)

The effect of eplerenone on the renin‐angiotensin‐aldosterone system of rats with thyroid dysfunction
por: Dizaye, Kawa, et al.
Publicado: (2019)

Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study
por: Bae, Jae Hyun, et al.
Publicado: (2021)

Incidence and factors associated with prescribing renin‐angiotensin‐system inhibitors in adult idiopathic nephrotic syndrome: A nationwide cohort study
por: Nishiwaki, Hiroki, et al.
Publicado: (2021)

Increased Endogenous Activity of the Renin-Angiotensin System Reduces Infarct Size in the Rats with Early Angiotensin II-dependent Hypertension which Survive the Acute Ischemia/Reperfusion Injury
por: Husková, Zuzana, et al.
Publicado: (2021)

Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation
por: Aoki, Taro, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Mitochondria-Endoplasmic Reticulum Crosstalk in Parkinson’s Disease: The Role of Brain Renin Angiotensin System Components
por: Sunanda, Tuladhar, et al.
Publicado: (2021)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
por: Pierzchlińska, Anna, et al.
Publicado: (2021)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study
por: Vilstrup, Frida, et al.
Publicado: (2023)

Systematic Review and Meta-Analysis of Renin–Angiotensin–Aldosterone System Blocker Effects on the Development of Cardiovascular Disease in Patients With Chronic Kidney Disease
por: Yanai, Katsunori, et al.
Publicado: (2021)

Inflammatory markers in paroxysmal atrial fibrillation and the protective role of renin-angiotensin-aldosterone system inhibitors
por: ROŞIANU, ŞTEFAN HORIA, et al.
Publicado: (2013)

GENETIC INFLUENCE ON THE RENIN-ANGIOTENSIN SYSTEM : EVIDENCE FOR A RENIN INHIBITOR IN HYPERTENSION-PRONE RATS
por: Iwai, Junichi, et al.
Publicado: (1970)

A Novel Modulator of the Renin–Angiotensin System, Benzoylaconitine, Attenuates Hypertension by Targeting ACE/ACE2 in Enhancing Vasodilation and Alleviating Vascular Inflammation
por: Zhang, Qi-Qiang, et al.
Publicado: (2022)

Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway
por: Wang, Yan-Ni, et al.
Publicado: (2022)

Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
por: Shukla, Ashwin Kumar, et al.
Publicado: (2021)

Safety of the neprilysin/renin-angiotensin system inhibitor LCZ696
por: Li, Bo, et al.
Publicado: (2017)

Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis
por: Zhu, Qianqian, et al.
Publicado: (2016)

Renin-Angiotensin System Inhibitors in COVID-19: Current Concepts
por: Mahajan, Kunal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iq93gls7uvvfkguoq4g0ou6q7h